Quality by Design Training in Cyprus

Build Quality into Every Product

Master the science-based QbD approach that Cyprus pharmaceutical and biopharma teams use to design quality into products from the start. This instructor-led programme, delivered by a specialist Quality by Design training company, equips formulation, analytical, process and regulatory professionals to apply the ICH Q8 to Q11 framework, QTPP, risk assessment, Design of Experiments and control strategy on real development work.

Flexible

Training Schedules

Instructor-led

Mode

Hours

13.3K+ already enrolled

4.1 (2330+ Reviews)

6 enrolled this week

Want to Train Your Team?

Master Quality by Design and Lead Excellence in Cyprus

Starts from

EUR 400

What Is Quality by Design in Pharmaceutical Development?A Practical Skill for Cyprus Pharma Teams

Quality by Design (QbD) is a systematic, science-based approach to pharmaceutical and biopharmaceutical development that builds quality into a product from the design stage rather than testing it in at the end. The Quality by Design Training in Cyprus gives you practical command of this approach, grounded in the ICH Q8(R2), Q9, Q10 and Q11 guidelines that the FDA and EMA now expect behind modern development and manufacturing submissions.

You learn to move from a Quality Target Product Profile (QTPP) and Critical Quality Attributes (CQAs) through structured risk assessment, Design of Experiments (DoE) and a defined design space to a robust control strategy. This is the language that Cyprus generics and biopharma manufacturers use every day to keep products consistent and audit-ready.

The programme suits formulation and analytical scientists, process development engineers, quality assurance teams and CMC regulatory professionals. If you want to replace trial-and-error development with a method employers trust, this is a clear place to start with Invensis Learning.

Key Highlightsof the Quality by Design Training Course

End-to-End Skill Development

Structured Quality by Design training in the Cyprus is designed to help learners understand QbD principles, regulatory frameworks, and pharmaceutical product development methodologies covered in the program
Course content aligned with current ICH Q8, Q9, and Q10 guideline expectations, real-world pharmaceutical quality requirements, and practical learning objectives for Cyprus professionals delivered through a comprehensive Quality by Design training program
Real-world examples and scenario-based learning to help learners connect QbD concepts with everyday pharmaceutical development, manufacturing, and quality assurance situations
Guided learning support to help participants strengthen understanding, improve confidence, and apply QbD principles effectively across product development and manufacturing roles

Structured Courseware and Learning Resources

Access to organized QbD course materials including QTPP definition worksheets, CQA and CMA identification templates, CPP mapping guides, and DoE reference cards designed to support step-by-step learning
Topic-wise learning resources, exercises, and knowledge checks to reinforce understanding of Design Space, control strategies, and risk assessment tools
Practice activities, assignments, and scenario-based exercises to help learners apply QbD concepts in realistic pharmaceutical product development and manufacturing quality situations
Supplementary learning aids such as risk assessment matrices, Design Space configuration worksheets, RTRT implementation checklists, and control strategy development guides

Instructor-Led, Practical Learning Experience

Live interactive sessions delivered by experienced QbD practitioners with hands-on domain expertise across pharmaceutical, biotechnology, and manufacturing sectors
Real-world examples, case discussions, and applied QbD exercises to improve practical understanding of QTPP definition, CQA identification, DoE applications, and Design Space configuration
Opportunities to ask questions, clarify doubts, and participate in trainer-led discussions on risk assessment, CPP mapping, and regulatory compliance requirements
Training approach focused on helping learners apply QbD concepts confidently at work, not just complete the course content

Flexible Learning Support in Cyprus

Instructor-led training formats available for individual learners and corporate teams across the Cyprus
Options include live virtual classroom training, onsite training, and customized group training depending on availability and organizational requirements
Learning support designed to help participants stay on track before, during, and after the Quality by Design training
Additional revision and post-training support may be available based on the selected course format

Learn the Core Concepts Covered in the Course

Understand QbD fundamentals, background, key drivers, and the regulatory guidance documents including ICH Q8, Q9, and Q10 that shape modern pharmaceutical development
Learn how to define QTPP, identify CQAs, CMAs, and CPPs, apply DoE, configure Design Space, and develop control strategies based on the course curriculum
Explore practical use cases showing how QbD is applied in pharmaceutical, biotechnology, healthcare, and manufacturing environments
Build role-relevant knowledge of risk assessment and management, real-time release testing, and regulatory compliance that supports better quality decisions in product development

Practice, Assessment, and Completion Support

Practice defining QTPP, identifying CQAs and CMAs, mapping CPPs, and applying DoE through exercises and scenario-based activities
Use assessments to identify knowledge gaps in QbD concepts and strengthen understanding of Design Space and control strategy development
Receive guidance from instructors to improve understanding of QbD tools and stay aligned with course objectives
Earn a course completion certificate after successfully meeting the training requirements

Career and Workplace Application

Build practical QbD skills that can support career growth, role advancement, or improved pharmaceutical quality performance in the Cyprus
Strengthen confidence in applying QTPP definition, CQA identification, DoE, Design Space, and risk management concepts to real-world product development challenges
Improve professional credibility through structured, skill-focused Quality by Design training recognized across Cyprus pharmaceutical and manufacturing industries
Support enterprise capability building through Quality by Design corporate training for employees across pharmaceutical, biotechnology, healthcare, and manufacturing organizations.

Quality by Design Training Eligibility in the CyprusWho Can Enroll?

No formal prerequisites are required to enroll in the Quality by Design training program
Basic familiarity with quality assurance concepts is helpful but not mandatory for enrollment
Professionals from pharmaceutical, biotechnology, healthcare, and manufacturing industries are well-suited for this training
Individuals and corporate teams seeking to build QbD knowledge and apply regulatory-aligned product development principles are eligible to enroll
Learners with backgrounds in quality, regulatory affairs, process engineering, and production management will find the content directly applicable to their roles

Why QbD Skills Pay off on the JobFor Professionals and Teams in Cyprus

For Individuals

The Quality by Design programme helps pharmaceutical professionals turn regulatory expectation into practical capability. You gain the tools to design robust products and processes, reduce manufacturing deviations, and support cleaner regulatory submissions. Whether you work in formulation, analytics, process development, quality assurance or regulatory affairs, the training connects the ICH framework to the decisions you make on live projects.

For professionals in Cyprus pharmaceutical and biopharma organisations, QbD fluency is a genuine differentiator. You leave able to construct a QTPP, identify CQAs, plan a DoE and build a control strategy that stands up to scrutiny.

Design quality into products from the start instead of testing for it at the end
Apply the ICH Q8 to Q11 framework with confidence in day-to-day development work
Build and defend a QTPP, CQAs and a science-based control strategy
Run and interpret Design of Experiments to define a reliable design space
Lead risk assessments using Ishikawa diagrams and FMEA with RPN prioritisation
Speak the QbD language that Cyprus generics and biopharma employers value
Contribute directly to CMC submission sections and inspection readiness

For Organizations

Quality by Design group training helps pharmaceutical and biopharma organisations build development capability across the whole team. Delivered for R&D, process development, quality and regulatory groups, it turns ICH guidance into a common way of working. For manufacturers connecting product design to consistent, compliant output, the training offers a scalable, practical solution.

If your teams still rely on empirical development and end-product testing, QbD training creates a systematic, risk-based method. Cross-functional groups gain a standardised approach to QTPP, CQA identification, DoE and control strategy.

Builds a shared QbD language across formulation, analytical, process and quality teams
Reduces manufacturing deviations and costly late-stage rework
Strengthens submissions and inspection readiness for EU and FDA markets
Embeds ICH Q8 to Q11 practice into your development stage gates
Applies QbD tools directly to your own live product development projects
Supports faster, more predictable scale-up and technology transfer
Available onsite, live virtual or blended for cross-functional groups

Where QbD Skills Take You in Cyprus PharmaRoles, Sectors and Demand

Quality by Design training and the skills it builds open doors across Cyprus's export-driven pharmaceutical sector, where generics and biopharma manufacturers run EU-GMP plants that ship to more than 120 countries. QbD-capable professionals move into formulation science, process development, analytical science, quality assurance and CMC regulatory roles. As the FDA and EMA push for stronger process understanding, employers increasingly want people who can apply the ICH framework in practice, and here is what the market shows.

EUR 462m

Cyprus pharma manufacturing market

IBISWorld 2025, about 5.6% CAGR

120+ countries

Pharmaceutical exports reach

Cyprus Profile, Medochemie 2026

EUR 1,821 to 4,722

Regulatory Affairs Manager pay

per month gross, Paylab 2026

EUR 1,304 to 2,791

Quality management roles pay

per month gross, Paylab 2026

SECTORS HIRING

—Generic Medicines Manufacturing
—Biopharmaceuticals and Biosimilars
—Active Pharmaceutical Ingredient (API) Production
—Contract Development and Manufacturing (CDMOs)
—Regulatory Affairs and CMC Consulting
—Quality Assurance and GMP Compliance

GROWTH TRENDS

—Pharma manufacturing market around EUR 462m, growing about 5.6% a year
—Generics exports to 120-plus countries driving EU-GMP demand
—FDA and EMA increasingly expecting QbD evidence in submissions
—PAT and continuous manufacturing raising demand for process understanding
—Cross-functional QbD talent scarce versus general quality staff
—Renewable-powered, export-focused plants scaling capacity

Sources: IBISWorld (Cyprus pharmaceutical manufacturing) 2025-2026; Cyprus Profile; Paylab (Cyprus) 2026; Statista; Invensis Learning research.

Designation

Quality by Design Professionals in Cyprus : Salary Insights and Trends

Hiring Companies in Cyprus

€19K

Min

€26K

Average

€38K

Max

Paylab · worldsalaries (Cyprus) 2026

MedochemieRemedicaCodal Synto

Source: Medochemie · Remedica · Codal Synto

Market Pressures Making QbD Skills Essential in Cyprus

The Test-And-Fix Trap

Many teams still set specifications empirically and rely on end-product testing to catch problems. QbD replaces this with process understanding that predicts and controls quality before it fails.

QbD builds process understanding, not testing gates

Rising EU and FDA Expectations

Regulators now expect QbD evidence in CMC submissions. Cyprus exporters shipping to regulated markets need people who can build a QTPP, design space and control strategy that reviewers accept.

QbD builds submission-ready development evidence

Scale-Up and Tech Transfer Risk

Moving from lab to commercial scale often triggers deviations and delays. A defined design space and control strategy make scale-up and technology transfer far more predictable.

QbD builds design-space and control-strategy skills

Cross-Functional Skills Gap

QbD needs formulation, analytical, process, quality and regulatory teams to speak one language. That joined-up capability is scarce compared with the pool of general quality staff.

QbD gives teams one shared language

Cost and Deviation Pressure

Margin pressure in generics rewards manufacturers who cut rework and out-of-specification batches. QbD-led development reduces deviations and protects consistent, profitable output.

QbD builds portfolio-grade development discipline

PAT and Continuous Manufacturing

Process Analytical Technology and continuous lines demand real-time process understanding. QbD provides the risk assessment and design-space thinking these modern methods rely on.

QbD underpins real-time process control

Sources: IBISWorld 2025-2026; Cyprus Profile; ICH Q8 to Q11 and FDA PAT framework; Invensis Learning research.

QbD is becoming the default language of pharmaceutical development. Build the skills Cyprus manufacturers need to design quality in and keep products audit-ready. Start your QbD journey today.

Your Cyprus Career Transformation

Where You Stand Today,

And What QbD Fluency Changes

Cyprus's pharmaceutical sector is export-led and quality-driven, and employers increasingly separate professionals who can apply QbD from those who only test at the end. Here is which side of that line you want to be on.

Today

Development leans on trial and error and end-product testing

After QbD

You design quality in using QTPP, CQAs and a defined design space

Today

Submissions and audits expose gaps in process understanding

After QbD

You build control strategies that satisfy EU-GMP, FDA and EMA reviewers

Today

Scale-up brings deviations you cannot fully explain

After QbD

You use DoE and design space to make scale-up predictable

You master QbD

Before

Quality seen as a testing gate at the end of the line

Now you have

A science-based method that builds quality in from the design stage

Before

Limited grasp of the ICH framework behind modern submissions

Now you have

Working command of the ICH Q8 to Q11 guidelines regulators expect

Before

Risk assessments done informally, if at all

Now you have

Structured Ishikawa and FMEA risk assessment with RPN prioritisation

Before

A general quality profile much like many others

Now you have

A cross-functional QbD skill set Cyprus employers actively seek

"In modern pharma, the gap between testing quality and designing it in is exactly the gap employers now pay to close."

Join 50,000+ professionals who trained with Invensis Learning and built new skills.

Sources: Paylab (Cyprus) 2026; IBISWorld 2025-2026; worldsalaries.com.

Module 1: Introduction to QbD

Background and key drivers that led to the adoption of Quality by Design in pharmaceutical development
Regulatory guidance documents including ICH Q8, Q9, and Q10 that define the QbD framework
QbD development process flow from concept and design through to manufacturing and regulatory submission

Module 2: QbD Tools and Techniques

Risk management principles and tools used to identify, assess, and control quality risks in product development
Design of Experiments (DoE): fundamentals, design types, and how DoE is used to understand process variability
Design Space definition and control strategies: how boundaries are established and maintained throughout the product lifecycle

Module 3: Industry and Regulatory Perspective

Regulatory framework for QbD including agency expectations from the FDA, EMA, and ICH guidelines
Implementation challenges organizations face when transitioning from traditional to QbD-based development approaches
Real-world industry examples demonstrating how pharmaceutical and biotechnology organizations have adopted QbD

Module 4: Quality Target Product Profile (QTPP)

Definition of the Quality Target Product Profile and its role in guiding QbD-based product development decisions
How QTPP links patient needs and regulatory requirements to specific product quality attributes and design objectives
Practical steps for defining a QTPP for pharmaceutical and biotechnology products

Module 5: Critical Quality Attributes, Critical Material Attributes, and Critical Process Parameters

Identifying Critical Quality Attributes (CQAs): what they are, how to define them, and why they are central to QbD
Critical Material Attributes (CMAs): how raw material properties influence product quality and must be controlled
Critical Process Parameters (CPPs): identifying process parameters that impact CQAs and require monitoring and control

Module 6: Statistical Design of Experiments

Fundamentals of statistical DoE including full factorial, fractional factorial, and response surface methodologies
Applications of DoE in pharmaceutical process development and optimization
Interpreting DoE results to establish design space boundaries and process understanding

Module 7: Design Space and Process Control

Design Space concept: defining the multidimensional combination of input variables and process parameters that provide quality assurance
Implementation of Design Space within regulatory submissions and manufacturing control strategies
Continuous process verification and how Design Space supports process control across the product lifecycle

Module 8: Risk Assessment and Management

Risk assessment methodologies used in QbD including FMEA, Ishikawa diagrams, and risk ranking tools
Applying risk management principles to product development decisions, process design, and control strategy development
Linking risk assessment outcomes to Design Space boundaries and CQA control strategies

Module 9: Real-time Release Testing (RTRT)

RTRT concept: replacing end-product testing with in-process monitoring and real-time quality assurance
Regulatory requirements and industry expectations for RTRT implementation in pharmaceutical manufacturing
Practical considerations for implementing RTRT as part of a QbD-based control strategy

Module 10: Case Studies and Practical Applications

Pharmaceutical and biotechnology case studies demonstrating end-to-end QbD implementation from QTPP to RTRT
Practical group exercises and scenario analysis applying QbD tools including QTPP definition, CQA identification, DoE, and risk assessment
Lessons learned and best practices from real QbD projects in pharmaceutical, biotechnology, and manufacturing environments

Course Curriculumof the Quality by Design Training

The online Quality by Design training course curriculum in the Cyprus is structured across ten modules, taking learners from foundational QbD background and regulatory guidance through to real-world case studies and practical applications in pharmaceutical, biotechnology, and manufacturing environments.

100% Secure and Safe download

Module 1: Introduction to QbD

Background and key drivers that led to the adoption of Quality by Design in pharmaceutical development
Regulatory guidance documents including ICH Q8, Q9, and Q10 that define the QbD framework
QbD development process flow from concept and design through to manufacturing and regulatory submission

Shifts your thinking from testing quality in at the end to designing it in from the start.

100% Secure and Safe download

The QbD Tools You Will MasterPractical Skills You Can Apply at Work

In this Quality by Design training you will learn to apply every core QbD tool, from the Quality Target Product Profile through to the control strategy. By the end you can plan, run and defend a science-based development approach aligned to the ICH guidelines.

QTPP and Critical Quality Attributes

Construct a Quality Target Product Profile from patient and clinical needs, then identify and classify the Critical Quality Attributes that determine product quality, safety and efficacy.

Risk Assessment with Ishikawa and FMEA

Map potential sources of variation with fishbone diagrams and rank material-attribute and process-parameter risks using FMEA and Risk Priority Numbers, so you focus effort where it matters most.

Design of Experiments and Design Space

Select and interpret screening and response-surface DoE designs, then define a design space with Normal Operating and Proven Acceptable Ranges that gives assurance of quality.

Control Strategy Development

Turn risk assessment and DoE results into a holistic control strategy spanning material controls, process parameter ranges, in-process controls and end-product testing.

Process Analytical Technology (PAT)

Apply PAT tools such as NIR and Raman spectroscopy to monitor critical attributes in real time, and understand how real-time release testing supports modern manufacturing.

QbD in Regulatory Submissions

Structure QbD evidence for CTD Section 3.2.P.2, link it across the submission, and see how a strong control strategy eases post-approval change management under ICH Q12.

Who Should TakeQuality by Design Training in Cyprus?

Process Engineers

QC Analysts

Engineering Teams

Technical Staff

Production Managers

Distribution Managers

Regulatory Affairs Specialists

Quality Assurance Professionals

Who Can Take This Certification Training

Quality by Design Training Modesfor Professionals and Teams

We offer flexible training formats designed to suit different learning preferences, schedules, and professional goals. Whether you prefer self-paced learning or a structured, corporate, instructor-led experience, choose the option that best supports your skill development journey with the best Quality by Design online training options.

Quality by Design Live Virtual Training

Live online instructor-led sessions
Interactive discussions and virtual activities
Expert guidance from experienced trainers
Practice assessments and revision support
Dedicated Q&A sessions for concept clarification
Fixed schedules for accountability and momentum
Small batch sizes for personalized attention
Access from any location with internet connectivity

EUR 400

Attend fully interactive weekday Quality by Design training sessions from anywhere while benefiting from real-time instructor guidance and collaborative learning experiences.

Best For: Professionals seeking the flexibility of online learning without compromising on live instructor interaction.

Quality by Design Classroom Training

Instructor-led classroom sessions
Interactive discussions and group activities
Real-world examples and practical exercises
Structured learning with fixed schedules
Opportunities for peer networking and collaboration
Practice assessments and knowledge checks
Dedicated Q&A and concept clarification
Immediate trainer feedback and support

Learn through face-to-face sessions led by experienced instructors in a collaborative classroom environment. This classroom Quality by Design training combines expert guidance, peer interaction, and hands-on activities to create an engaging learning experience.

Best For: Learners who prefer in-person interaction, structured schedules, and collaborative learning experiences.

Quality by Design Corporate Group Training

Customized training aligned to organizational goals
Flexible delivery: onsite, virtual, hybrid, or blended
Scheduling tailored to business availability
Role-based examples and industry-relevant discussions
Progress tracking and learner assessments where applicable
Dedicated coordination and administrative support
Consistent learning experiences across teams
Scalable delivery for local, regional, or global workforces

Designed for organizations that want to build capabilities at scale, standardize knowledge, and support workforce development through customized team learning initiatives.

Best For: Organizations looking to upskill employees, address capability gaps, and deliver consistent training across teams.

Quality by Design Focused 1-to-1 Training

One-to-one instructor attention
Customized learning plans and objectives
Flexible scheduling based on availability
Personalized feedback and coaching
Additional focus on challenging topics
Targeted practice and revision support
Faster clarification of questions and concepts
Learning pace is adapted to individual needs

Receive personalized instruction tailored to your goals, pace, and learning requirements through dedicated sessions from our trusted Quality by Design training company.

Best For: Professionals seeking personalized guidance, accelerated learning, or focused support to achieve specific outcomes.

Quality by Design Live Virtual Training

Live online instructor-led sessions

Interactive discussions and virtual activities

Expert guidance from experienced trainers

Practice assessments and revision support

Dedicated Q&A sessions for concept clarification

Fixed schedules for accountability and momentum

Small batch sizes for personalized attention

Access from any location with internet connectivity

Starts from

EUR 400

Please Note:Attend fully interactive weekday Quality by Design training sessions from anywhere while benefiting from real-time instructor guidance and collaborative learning experiences.

Best For: Professionals seeking the flexibility of online learning without compromising on live instructor interaction.

Loading schedules…

Why Choose Invensis Learning for Quality by Design Training in CyprusExpert-Led, Flexible and Practical

Invensis Learning delivers structured Quality by Design training for pharmaceutical professionals and organisations that want to build real development capability. Our programmes combine experienced, practitioner trainers, flexible delivery formats and organised, practical courseware. As an ISO 9001:2015 and ISO 27001:2022 certified global training provider and trusted Quality by Design training company, we support learners across Cyprus and worldwide with live virtual, classroom and corporate options, and dedicated learner support before, during and after the course.

Experienced trainers with real pharmaceutical and quality management practice
Flexible live virtual, classroom and onsite delivery to fit working teams
Practical, hands-on QbD exercises using realistic development scenarios
Structured courseware covering the full ICH Q8 to Q11 framework
ISO 9001:2015 quality and ISO 27001:2022 information security certified
Dedicated learner support before, during and after training
Customised corporate programmes for cross-functional pharma teams
Trusted by professionals and organisations across 100-plus countries

24/7

Learner Support

50+

Industries Served

1-to-1

Doubt-Clearing Sessions

60+

Global Course Portfolio

ISO 9001:2015 Certified

ISO 27001:2022 Certified

Secure SSL Encryption

Leaders in Training industry for 12+ years

Over 5000 five star reviews

Level AA conformance, W3C WCAG 2.2

Quality by Design Training Locations in CyprusInstructor-led in-person Classroom training is available for group batches. All other public cohorts are delivered as Instructor-led Live Virtual. See available cohorts.

Quality by Design Training Location in Cyprus

Hilton Nicosia, 1, Achaion, Engomi, Nicosia - Lefkoşa, Nicosia Municipality, Nicosia District, Cyprus, 2413, Cyprus - Kıbrıs

Quality by Design Training Location in Cyprus

The Landmark Nicosia, 98, Archbishop Makariou III Avenue, Aghii Omologetis, Nicosia, Nicosia Municipality, Nicosia District, Cyprus, 1077, Cyprus - Kıbrıs

Corporate Quality by Design TrainingFor Your Cyprus Pharma Teams

Tailored QbD programmes for R&D, process, quality and regulatory teams
Delivered onsite, live virtual, hybrid or blended to suit your schedule
Apply QbD tools to your own live product development projects
Build a shared, ICH-aligned language across functions
Experienced trainers with pharmaceutical and GMP expertise
Progress tracking and dedicated coordination for group training
Scalable delivery for teams in Cyprus and global sites

What Our Learners Say

Finally Understood How the Pieces Fit

"The QbD training connected QTPP, CQAs, risk assessment and design space into one clear method. I now lead our formulation risk workshops with real confidence."

Andreas Georgiou

Formulation Scientist

0/0

DoE Finally Made Sense

"The hands-on Design of Experiments exercises were the highlight. I can plan a screening study and read a response surface without second-guessing myself now."

Maria Christodoulou

Analytical Scientist

0/0

Directly Useful for CMC Work

"Practical and well paced. The session on structuring QbD evidence for the control strategy and submission was exactly what my regulatory role needed."

Christos Ioannou

Regulatory Affairs Specialist

0/0

Aligned Our Whole Development Team

"We ran this onsite for our process and quality teams. Everyone now uses the same QbD language, and our risk assessments are far more structured."

Elena Papadopoulou

Head of Quality Assurance

Generic Medicines Manufacturer

0/0

Fewer Deviations After Training

"The trainer tailored examples to our products. Within a quarter our development team was applying design-space thinking and we saw cleaner scale-up."

Georgios Andreou

Process Development Manager

Biopharmaceutical Company

0/0

4.6

Ratings

100K+

Happy Learners

100+

Locations Worldwide

99%

Training Satisfaction

Enquire with us now

Drop us a query and our learning consultant will reach out to you shortly

Get Course Details & Pricing

Fill out this form and we will respond quickly.

We also deliver Quality by Design Training across multiple cities

Invensis Learning delivers industry-leading Quality by Design training solutions tailored for individuals and organizations.

LimassolNicosia

Explore Our Other Course Categories

Agile

Project Management

ITSM

DevOps

IT Governance

Other Related Courses

Foundation

Root Cause Analysis

Frequently Asked QuestionsHere's everything you may ask...

Quality by Design training is a practical, non-certification course that teaches the QbD approach to pharmaceutical and biopharmaceutical development. You learn to build quality into a product from the design stage using the ICH Q8, Q9, Q10 and Q11 framework, QTPP, CQAs, DoE and control strategy.

General

What is Quality by Design (QbD) training?

Is the QbD course worth it for my career in Cyprus?

Yes. Cyprus is an export-led pharmaceutical hub where EU-GMP manufacturers and regulators increasingly expect QbD-based development. The skills apply directly to formulation, process, analytical, quality and regulatory roles, making you more valuable on live projects. Talk to a learning advisor to see how it fits your goals.

Who should attend this QbD training?

The course suits formulation scientists, analytical and QC scientists, process development engineers, quality assurance teams and CMC regulatory professionals. It introduces QbD from first principles, so prior QbD experience is not required.

Which standards and guidelines does the course cover?

The training is grounded in the ICH quality guidelines: Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, Q10 Pharmaceutical Quality System and Q11 for drug substances. It also reflects FDA and EMA expectations and the FDA Process Analytical Technology framework.

Do I need prior experience to join?

No. There are no formal prerequisites. Familiarity with pharmaceutical development or GMP is helpful but not required, as the course builds QbD understanding from the ground up.

Pricing

How much does the QbD training cost in Cyprus?

Fees vary by delivery format, group size and schedule, so pricing is available on request. The course is offered for individual learners and as corporate group training. Request a quote for current pricing that fits your needs.

What is included in the course fee?

The fee typically includes instructor-led training across all QbD modules, practical tool exercises, structured courseware and learner support, plus a course completion certificate from Invensis Learning. Ask a learning advisor for the full inclusions on your chosen format.

Do you offer group or corporate pricing?

Yes. We offer corporate group training with tailored schedules and volume-based pricing for pharmaceutical and biopharma teams. Contact us for a customised quote for your organisation.

Are payment or instalment options available?

Yes. We accept major cards and bank transfers, with instalment options on selected plans. Speak with a learning advisor to choose the option that suits you.

Is there any separate assessment or exam fee?

No. This is a practical skills course with no examination and no separate exam fee. Learning is reinforced through hands-on exercises and case studies during the programme.

Assessment

Is there an exam for this QbD course?

No. Quality by Design training is a non-certification course with no examination. Your learning is reinforced through hands-on QbD tool exercises, pharmaceutical case studies and group discussion during the programme.

Do I receive anything on completion?

Yes. You receive a course completion certificate from Invensis Learning that recognises you have completed the programme. The QbD skills you gain are immediately applicable to development and manufacturing work.

How is my learning assessed?

There is no formal assessment. Instead, you apply QbD tools such as QTPP construction, CQA identification, risk assessment and design-space interpretation to realistic scenarios throughout the course.

Will I be able to apply QbD straight away?

Yes. After the course you can construct a QTPP, identify and classify CQAs, run risk assessments with Ishikawa and FMEA, plan a DoE, define a design space and build a control strategy for your projects.

Does the course lead to a regulated credential?

No. This is vendor-neutral skills training with no governing body, not a regulated credential. It builds the practical QbD capability that pharmaceutical employers value, grounded in the ICH guidelines.

Course Content

What topics does the QbD training cover?

The course covers QbD principles and the ICH regulatory context, QTPP and CQA identification, risk assessment, Design of Experiments and design space, Process Analytical Technology and control strategy, plus QbD case studies and regulatory submission.

Does it cover both small molecules and biologics?

Yes. The training addresses QbD for small molecule drug products such as tablets and injectables, and for biopharmaceuticals such as monoclonal antibodies and biosimilars, with case examples from both.

Are there hands-on exercises?

Yes. You work through practical exercises including QTPP construction, CQA and criticality assessment, Ishikawa risk mapping, DoE design selection and design-space interpretation, all based on realistic pharmaceutical development scenarios.

How long is the QbD training?

The programme runs as a focused one-day, eight-hour course covering all six QbD modules. It can also be delivered across two half-days, and corporate sessions can be tailored to your team's schedule.

What materials are provided?

You receive structured courseware covering the full QbD framework, worked case studies, tool templates and reference material aligned to the ICH Q8 to Q11 guidelines, so you can keep applying the methods after the course.

Enrollment

How do I enrol in the QbD course in Cyprus?

You can enrol through the Invensis Learning website. Choose your preferred format, complete your booking, and you will receive access to schedules, courseware and learning resources. See upcoming batches to get started.

What delivery formats are available?

The course is available online as live virtual instructor-led training, as classroom training, and as customised corporate onsite training, so you can pick the format that fits your schedule and team.

When can I start?

New live virtual and classroom sessions run regularly, and corporate cohorts can be scheduled to suit your organisation. Contact a learning advisor to see the next available dates for Cyprus.

Can this be delivered onsite for my team?

Yes. We deliver QbD training onsite or live virtual for cross-functional pharmaceutical teams, tailored to your products and processes. Ask about corporate and group options for your organisation.

Can I reschedule my booking?

Yes. Flexible options let you reschedule to another batch on selected plans. Contact our support team and we will help you arrange a suitable date.

Quality by Design Training in Cyprus

What Is Quality by Design in Pharmaceutical Development?A Practical Skill for Cyprus Pharma Teams

What Is Quality by Design in Pharmaceutical Development?A Practical Skill for Cyprus Pharma Teams

Key Highlightsof the Quality by Design Training Course

Quality by Design Training Eligibility in the CyprusWho Can Enroll?

Why QbD Skills Pay off on the JobFor Professionals and Teams in Cyprus

Where QbD Skills Take You in Cyprus PharmaRoles, Sectors and Demand

SECTORS HIRING

GROWTH TRENDS

Market Pressures Making QbD Skills Essential in Cyprus

The Test-And-Fix Trap

Rising EU and FDA Expectations

Scale-Up and Tech Transfer Risk

Cross-Functional Skills Gap

Cost and Deviation Pressure

PAT and Continuous Manufacturing

Where You Stand Today,

And What QbD Fluency Changes

Module 1: Introduction to QbD

Module 2: QbD Tools and Techniques

Module 3: Industry and Regulatory Perspective

Module 4: Quality Target Product Profile (QTPP)

Module 5: Critical Quality Attributes, Critical Material Attributes, and Critical Process Parameters

Module 6: Statistical Design of Experiments

Module 7: Design Space and Process Control

Module 8: Risk Assessment and Management

Module 9: Real-time Release Testing (RTRT)

Module 10: Case Studies and Practical Applications

Course Curriculumof the Quality by Design Training

Module 1: Introduction to QbD

The QbD Tools You Will MasterPractical Skills You Can Apply at Work

QTPP and Critical Quality Attributes

Risk Assessment with Ishikawa and FMEA

Design of Experiments and Design Space

Control Strategy Development

Process Analytical Technology (PAT)

QbD in Regulatory Submissions

Who Should TakeQuality by Design Training in Cyprus?

Quality by Design Training Modesfor Professionals and Teams

Quality by Design Live Virtual Training

Quality by Design Classroom Training

Quality by Design Corporate Group Training

Quality by Design Focused 1-to-1 Training

Quality by Design Live Virtual Training

Why Choose Invensis Learning for Quality by Design Training in CyprusExpert-Led, Flexible and Practical

Quality by Design Training Locations in CyprusInstructor-led in-person Classroom training is available for group batches. All other public cohorts are delivered as Instructor-led Live Virtual. See available cohorts.

Corporate Quality by Design TrainingFor Your Cyprus Pharma Teams

What Our Learners Say

Enquire with us now

Get Course Details & Pricing

We also deliver Quality by Design Training across multiple cities

Explore Our Other Course Categories

Other Related Courses

Poka Yoke

Lean Six Sigma Yellow Belt

Business Process Management

Six Sigma Awareness

7 QC Tools Training

Lean Six Sigma Black Belt

Quality Function Deployment

Lean IT

Lean Six Sigma Green Belt

Minitab Essentials

Design for Six Sigma

Lean Fundamentals